Choose your location

Current selection

Sweden
English
Canada
United States
Australia
Hong Kong
Japan
New Zealand
Singapore
South Korea
Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Ireland
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Portugal
Sweden
Switzerland
United Kingdom
Global Equities
Looking ahead to keep our clients on the right side of change
We live in an era of unprecedented change. Change that is upending established business models and shaping the direction of global financial markets. Ecommerce, artificial intelligence, demographics and connectivity - the impact of change can be seen across all sectors and industries. The pandemic has served to accelerate many of the trends that were already in play. Some companies have seen their economic futures pulled forward, while others may never make it back. Find out how our global equities expertise could keep your clients’ portfolios positioned for change.
Identifying real insights of change
 
In an era of extreme disruption, what distinguishes intelligent investment decisions is research: the ability to quantify change, fully understand its dimensions, and correctly identify the stocks most likely to benefit from it.
 
That’s why our team of 165 equity analysts goes beyond the numbers, getting out into the field to see first-hand how companies are performing today and, more importantly, to make skilled judgements about how they think they’ll perform in the future.


Our Thinking

Read our thoughts on global markets:

 

September 2022 / INVESTMENT INSIGHTS

The Regime Change in Markets Demands Fresh Ideas

The Regime Change in Markets Demands Fresh Ideas

The Regime Change in Markets Demands Fresh...

Alpha potential is still available for those who adapt to the new paradigm

By Justin Thomson

Justin Thomson Head of International Equity

August 2022 / INVESTMENT INSIGHTS

Are Frontier Markets Still the Great Untapped Opportunity?

Are Frontier Markets Still the Great Untapped Opportunity?

Are Frontier Markets Still the Great Untapped...

This dynamic part of the global equity market remains significantly neglected

By Johannes Loefstrand

Johannes Loefstrand Portfolio Manager, T. Rowe Price Frontier Markets Equity Strategy

May 2022 / VIDEO

Big Pharma: Navigating a Golden Age of Innovation

Big Pharma: Navigating a Golden Age of Innovation

Big Pharma: Navigating a Golden Age of Innovation

Investors should focus on trends in the duration and diversity of a large-cap biopharma...

By Jeffrey Holford

Jeffrey Holford Vice President

April 2022 / INVESTMENT INSIGHTS

Q&A With Justin Thomson

Q&A With Justin Thomson

Q&A With Justin Thomson

T. Rowe Price’s CIO for International Equities

By Justin Thomson

Justin Thomson Head of International Equity

April 2022 / INVESTMENT INSIGHTS

A Closer Look at Inflation and the “Value Rally”

A Closer Look at Inflation and the “Value Rally”

A Closer Look at Inflation and the “Value...

Discovering new ideas that deliver value

By David J. Eiswert

David J. Eiswert Portfolio Manager

December 2021 / VIDEO

Global Equities: Thoughts from a Value Investor

Global Equities: Thoughts from a Value Investor

Global Equities: Thoughts from a Value Investor

Where are the value opportunities today and how will the environment evolve in 2022?

By Sebastien Mallet

Sebastien Mallet Portfolio Manager, Global Value Equity Fund

December 2021 / GLOBAL EQUITIES

Higher Oil Prices Unlikely to Prove Sustainable

Higher Oil Prices Unlikely to Prove Sustainable

Higher Oil Prices Unlikely to Prove Sustainable

Supply response and productivity gains should pressure prices.

By Shinwoo Kim

Shinwoo Kim Portfolio Manager

October 2021 / INVESTMENT INSIGHTS

Demand Stimulus and Inflationary Pressures Loom for Post-Election Germany

Demand Stimulus and Inflationary Pressures Loom for Post-Election Germany

Demand Stimulus and Inflationary Pressures...

The new government will likely prioritize social justice and green policies.

By Tomasz Wieladek

Tomasz Wieladek T.Rowe Price Chief European Economist

September 2021 / VIDEO

The Three Drivers of Innovation in Biotech Stocks

The Three Drivers of Innovation in Biotech Stocks

The Three Drivers of Innovation in Biotech...

Innovation in the biotech industry is creating investment opportunities in stocks...

By John Hall

John Hall Investment Analyst

3 reasons to choose T. Rowe Price for global equities

Global coverage:
Our size and resources mean we can secure access to top management and analyse opportunities anywhere in the world, at any time to find the best ideas for our clients’ portfolios.

 
Differentiated ideas:
We hire experts with varied backgrounds and experiences who can consistently challenge the consensus and bring unique perspectives to the decision-making process.

 
Repeatable results:
Our track record highlights the consistency and attribution of our returns over a cycle: idiosyncratic alpha from a diversified set of stocks, sectors and factors.
Funds in Focus

Browse our range of Global Equity strategies:

 
RELATED FUND
SICAV
Class I
ISIN LU0143563046
We look for companies that we believe have the potential for improving economic returns in the future and that we can buy at an attractive price. In a world of secular change, this means understanding the forces enhancing or erasing durable competitive advantage to correctly identify the winners and losers ahead of the market. The manager is not constrained by the funds benchmark, which is used for performance comparison purposes only.
View More...
RELATED FUND
SICAV
Class I
ISIN LU0382933116
An actively managed, growth-oriented portfolio of typically 150-200 companies, seeking to harness the best ideas of our global research team. The fund offers broad exposure to the global equity universe, both developed and emerging markets, investing in around 30 countries.
View More...
RELATED FUND
SICAV
Class I
ISIN LU1244139827
An actively managed, global, all-cap fund that seeks to invest in companies that can benefit from innovation in technology. We invest in around 30-80 high conviction ideas seeking to identify secular growth themes and companies positioned on the right side of change. The fund is categorised as Article 8 under Sustainable Finance Disclosure Regulation (SFDR).
View More...
RELATED FUND
SICAV
Class I
ISIN LU0272423913
An actively managed, broadly diversified portfolio of around 90-120 stocks of natural resources or commodities-related companies. The universe includes companies that own or develop natural resources and other basic commodities and companies both upstream and downstream in the supply chain.
View More...
RELATED FUND
SICAV
Class I
ISIN LU0859255472
An actively managed, conviction-based global portfolio of around 80-100 attractively valued companies. We invest across the value spectrum, from deep value through to higher quality, more defensive companies, seeking to deliver positive excess returns regardless of which value substyle is currently favoured by the market. The fund is categorised as Article 8 under Sustainable Finance Disclosure Regulation (SFDR).
View More...

Risks - The following risks are materially relevant to the fund (refer to prospectus for further details):

Country risk (China) - all investments in China are subject to risks similar to those for other emerging markets investments. In addition, investments that are purchased or held in connection with a QFII licence or the Stock Connect program may be subject to additional risks. Country risk (Russia and Ukraine) - in these countries, risks associated with custody, counterparties and market volatility are higher than in developed countries. Currency risk - changes in currency exchange rates could reduce investment gains or increase investment losses. Emerging markets risk - emerging markets are less established than developed markets and therefore involve higher risks. Small and mid-cap risk - stocks of small and mid-size companies can be more volatile than stocks of larger companies. Style risk - different investment styles typically go in and out of favour depending on market conditions and investor sentiment.

Past performance is not a reliable indicator of future performance.

Source for performance: T. Rowe Price. Fund performance is calculated using the official NAV with dividends reinvested, if any. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested. It will be affected by changes in the exchange rate between the base currency of the fund and the subscription currency, if different. Sales charges (up to a maximum of 5% for the A Class), taxes and other locally applied costs have not been deducted and if applicable, they will reduce the performance figures.

Daily performance data is based on the latest available NAV.  

The Funds are sub-funds of the T. Rowe Price Funds SICAV, a Luxembourg investment company with variable capital which is registered with Commission de Surveillance du Secteur Financier and which qualifies as an undertaking for collective investment in transferable securities (“UCITS”). Full details of the objectives, investment policies and risks are located in the prospectus which is available with the key investor information documents in English and in an official language of the jurisdictions in which the Funds are registered for public sale, together with the articles of incorporation and the annual and semi-annual reports (together “Fund Documents”). Any decision to invest should be made on the basis of the Fund Documents which are available free of charge from the local representative, local information/paying agent or from authorised distributors. They can also be found along with a summary of investor rights in English at www.troweprice.com. The Management Company reserves the right to terminate marketing arrangements.

IMPORTANT INFORMATION

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.